PRESS RELEASE published on 01/17/2024 at 08:00, 2 years 1 month ago Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
Published on 02/18/2026 at 15:15, 1 hour 42 minutes ago Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Published on 02/18/2026 at 15:00, 1 hour 57 minutes ago Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 2 hours 32 minutes ago Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Published on 02/18/2026 at 14:00, 2 hours 57 minutes ago Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Published on 02/18/2026 at 14:00, 2 hours 57 minutes ago Datametrex Receives $1M Order from Fortune 500 Client
Published on 02/18/2026 at 15:50, 1 hour 7 minutes ago CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond
Published on 02/18/2026 at 15:48, 1 hour 8 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 02/18/2026 at 15:47, 1 hour 9 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders PLC
Published on 02/18/2026 at 15:46, 1 hour 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Ltd
Published on 02/18/2026 at 15:44, 1 hour 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: NCC Group PLC
Published on 02/18/2026 at 13:45, 3 hours 11 minutes ago NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède
Published on 02/18/2026 at 11:00, 5 hours 56 minutes ago Mise à disposition des documents préparatoires à l'AG
Published on 02/18/2026 at 08:07, 8 hours 50 minutes ago TERACT - Modification du calendrier financier